Firms & Funds Talking Deal Prices: CD&R sells PharMEDium for 20x EBITDA, high-yield credit shows strain Steve Gelsi - October 26 2015 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
